358 related articles for article (PubMed ID: 10319787)
21. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat.
Xu XJ; Puke MJ; Verge VM; Wiesenfeld-Hallin Z; Hughes J; Hökfelt T
Neurosci Lett; 1993 Apr; 152(1-2):129-32. PubMed ID: 8515864
[TBL] [Abstract][Full Text] [Related]
22. Clonidine, but not morphine, delays the development of thermal hyperesthesia induced by sciatic nerve constriction injury in the rat.
Yamamoto T; Nozaki-Taguchi N
Anesthesiology; 1996 Oct; 85(4):835-45. PubMed ID: 8873554
[TBL] [Abstract][Full Text] [Related]
23. Effect of prior treatment with ultra-low-dose morphine on opioid- and nerve injury-induced hyperalgesia in rats.
Wala EP; Sloan PA; Holtman JR
J Opioid Manag; 2011; 7(5):377-89. PubMed ID: 22165037
[TBL] [Abstract][Full Text] [Related]
24. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates.
Upadhya MA; Dandekar MP; Kokare DM; Singru PS; Subhedar NK
Neuropeptides; 2009 Aug; 43(4):303-14. PubMed ID: 19556004
[TBL] [Abstract][Full Text] [Related]
25. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
Front Immunol; 2020; 11():615327. PubMed ID: 33408720
[TBL] [Abstract][Full Text] [Related]
26. Prolonged morphine treatment relieves thermal hyperalgesia in rats with sciatic nerve constriction injury.
Chu KS; Chen HP; Kang FC; Tsai YC
Kaohsiung J Med Sci; 2000 Jan; 16(1):20-5. PubMed ID: 10741012
[TBL] [Abstract][Full Text] [Related]
27. Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat.
Kovelowski CJ; Ossipov MH; Sun H; Lai J; Malan TP; Porreca F
Pain; 2000 Sep; 87(3):265-273. PubMed ID: 10963906
[TBL] [Abstract][Full Text] [Related]
28. Rapid development of nitric oxide-induced hyperalgesia depends on an alternate to the cGMP-mediated pathway in the rat neuropathic pain model.
Inoue T; Mashimo T; Shibata M; Shibuta S; Yoshiya I
Brain Res; 1998 May; 792(2):263-70. PubMed ID: 9593928
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy.
Kayser V; Lee SH; Guilbaud G
Neuroscience; 1995 Jan; 64(2):537-45. PubMed ID: 7700537
[TBL] [Abstract][Full Text] [Related]
30. Respective pharmacological features of neuropathic-like pain evoked by intrathecal BDNF versus sciatic nerve ligation in rats.
M'Dahoma S; Barthélemy S; Tromilin C; Jeanson T; Viguier F; Michot B; Pezet S; Hamon M; Bourgoin S
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2118-30. PubMed ID: 26343858
[TBL] [Abstract][Full Text] [Related]
31. Preemptive effects of intrathecal cyclooxygenase inhibitor or nitric oxide synthase inhibitor on thermal hypersensitivity following peripheral nerve injury.
Lui PW; Lee CH
Life Sci; 2004 Oct; 75(21):2527-38. PubMed ID: 15363658
[TBL] [Abstract][Full Text] [Related]
32. The development of pain-related behaviour and opioid tolerance after neuropathy-inducing surgery and sham surgery.
Christensen D; Kayser V
Pain; 2000 Dec; 88(3):231-238. PubMed ID: 11068110
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of intracellular signaling pathways NF-κB and MEK1/2 attenuates neuropathic pain development and enhances morphine analgesia.
Popiolek-Barczyk K; Makuch W; Rojewska E; Pilat D; Mika J
Pharmacol Rep; 2014 Oct; 66(5):845-51. PubMed ID: 25149989
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats.
Coudoré-Civiale MA; Méen M; Fournié-Zaluski MC; Boucher M; Roques BP; Eschalier A
Br J Pharmacol; 2001 May; 133(1):179-85. PubMed ID: 11325808
[TBL] [Abstract][Full Text] [Related]
35. The effect of continuous morphine analgesia on chronic thermal hyperalgesia due to sciatic constriction injury in rats.
Backonja MM; Miletic G; Miletic V
Neurosci Lett; 1995 Aug; 196(1-2):61-4. PubMed ID: 7501258
[TBL] [Abstract][Full Text] [Related]
36. Effect of intrathecal octreotide on thermal hyperalgesia and evoked spinal c-Fos expression in rats with sciatic constriction injury.
Tsai YC; So EC; Chen HH; Wang LK; Chien CH
Pain; 2002 Oct; 99(3):407-413. PubMed ID: 12406515
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy.
Nichols ML; Lopez Y; Ossipov MH; Bian D; Porreca F
Pain; 1997 Feb; 69(3):317-322. PubMed ID: 9085307
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment with antiserum against dynorphin, substance P, or cholecystokinin enhances the morphine-produced anti-allodynia in the sciatic nerve ligated mice.
Wu HE; Schwasinger ET; Hong JS; Tseng LF
Neurosci Lett; 2005 Sep; 386(1):46-51. PubMed ID: 15982809
[TBL] [Abstract][Full Text] [Related]
39. The kainate receptor antagonist 2S,4R-4-methylglutamate attenuates mechanical allodynia and thermal hyperalgesia in a rat model of nerve injury.
Sutton JL; Maccecchini ML; Kajander KC
Neuroscience; 1999; 91(1):283-92. PubMed ID: 10336078
[TBL] [Abstract][Full Text] [Related]
40. Ethosuximide reduces allodynia and hyperalgesia and potentiates morphine effects in the chronic constriction injury model of neuropathic pain.
Hamidi GA; Ramezani MH; Arani MN; Talaei SA; Mesdaghinia A; Banafshe HR
Eur J Pharmacol; 2012 Jan; 674(2-3):260-4. PubMed ID: 22134003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
